Free Trial

Genprex (GNPX) Short Interest Ratio & Short Volume

Genprex logo
$2.02
-0.13 (-6.05%)
(As of 11/4/2024 ET)

Genprex Short Interest Data

Genprex (GNPX) has a short interest of 85,200 shares, representing 3.51% of the float (the number of shares available for trading by the public). This marks a 5.19% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 2.77 million shares to cover all short positions.

Current Short Interest
85,200 shares
Previous Short Interest
81,000 shares
Change Vs. Previous Month
+5.19%
Dollar Volume Sold Short
$28,490.88
Short Interest Ratio
0.0 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
2,590,000 shares
Float Size
2,430,000 shares
Short Percent of Float
3.51%
Today's Trading Volume
946,640 shares
Average Trading Volume
2,770,419 shares
Today's Volume Vs. Average
34%
Short Selling Genprex?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Genprex and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GNPX Short Interest Over Time

GNPX Days to Cover Over Time

GNPX Percentage of Float Shorted Over Time

Genprex Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/202485,200 shares $28,490.88 +5.2%3.5%0 $0.33
9/30/202481,000 shares $29,297.70 -66.9%3.3%0.2 $0.36
9/15/2024244,700 shares $102,774.00 +501.2%9.6%0.6 $0.42
8/31/202440,700 shares $27,873.40 -83.6%1.6%0.1 $0.68
8/15/2024247,400 shares $161,280.06 +430.9%9.7%1.1 $0.65
7/31/202446,600 shares $78,288.00 -16.6%2.3%0.5 $1.68
7/15/202455,900 shares $111,800.00 +10.5%2.7%0.6 $2.00
6/30/202450,600 shares $95,381.00 -39.2%2.5%0.5 $1.89
6/15/202483,200 shares $180,544.00 +75.9%4.0%0.8 $2.17
5/31/202447,300 shares $147,103.00 +20.1%2.3%0.4 $3.11
5/15/202439,400 shares $96,136.00 -21.2%1.9%0.8 $2.44
4/30/202450,000 shares $113,000.00 +0.6%2.5%0.9 $2.26
4/15/202449,700 shares $119,280.00 -29.0%2.7%0.6 $2.40
3/31/202470,000 shares $208,600.00 -12.8%3.8%0.8 $2.98
3/15/202480,300 shares $324,412.00 +23.7%5.6%1 $4.04
2/29/202464,900 shares $279,070.00 -35.3%4.5%1 $4.30
2/15/2024100,300 shares $439,314.00 +86.1%6.9%2 $4.38
1/31/202453,900 shares $409,640.00 +38.6%3.7%1.1 $7.60
1/15/20241,560,000 shares $339,768.00 +13.9%N/A4.2 $0.22
12/31/20231,370,000 shares $315,100.00 +25.7%N/A3.6 $0.23
12/15/20231,090,000 shares $229,990.00 -7.6%N/A3.3 $0.21
11/30/20231,180,000 shares $285,560.00 -11.9%N/A4 $0.24
11/15/20231,340,000 shares $348,400.00 -18.3%N/A4.5 $0.26
10/31/20231,640,000 shares $362,440.00 -8.9%N/A4.2 $0.22
10/15/20231,800,000 shares $585,000.00 +9.1%N/A4.2 $0.33
9/30/20231,650,000 shares $651,585.00 -6.8%N/A3.1 $0.39
9/15/20231,770,000 shares $901,815.00 +3.5%N/A2.5 $0.51
8/31/20231,710,000 shares $888,687.00 -19.0%N/A2.4 $0.52
8/15/20232,110,000 shares $1.19 million -17.3%N/A2.8 $0.57
7/31/20232,550,000 shares $1.94 million +11.8%N/A3.9 $0.76
7/15/20232,280,000 shares $1.88 million -22.5%N/A3.8 $0.82
6/30/20232,940,000 shares $2.79 million +55.6%N/A4.7 $0.95
6/15/20231,890,000 shares $1.61 million -6.0%N/A4.5 $0.85
5/31/20232,010,000 shares $1.73 million +6.9%N/A4.4 $0.86
5/15/20231,880,000 shares $1.52 million -16.8%N/A3.4 $0.81
4/30/20232,260,000 shares $1.85 million +37.0%N/A4.1 $0.82
4/15/20231,650,000 shares $1.37 million -4.1%N/A3 $0.83
3/31/20231,720,000 shares $1.57 million -11.3%N/A5 $0.91
3/15/20231,940,000 shares $1.60 million -29.2%N/A4.8 $0.83
2/28/20232,740,000 shares $3.51 million +52.2%N/A7.5 $1.28
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

2/15/20231,800,000 shares $2.86 million +2.9%N/A5.7 $1.59
1/31/20231,750,000 shares $2.57 million +6.1%N/A9.4 $1.47
1/15/20231,650,000 shares $2.36 million +13.0%N/A9.6 $1.43
12/30/20221,460,000 shares $2.12 million -2.0%N/A8.7 $1.45
12/15/20221,490,000 shares $1.77 million -4.5%N/A13.9 $1.19
11/30/20221,560,000 shares $2.11 million +0.7%N/A15.8 $1.35
11/15/20221,550,000 shares $2.09 million -1.9%N/A12.8 $1.35
10/31/20221,580,000 shares $2.15 million -1.9%N/A6.1 $1.36
10/15/20221,610,000 shares $2.14 million -8.0%N/A6 $1.33
9/30/20221,750,000 shares $2.47 million -0.6%N/A6.7 $1.41
9/15/20221,760,000 shares $2.94 million -5.4%N/A6.8 $1.67
8/31/20221,860,000 shares $2.98 million +16.3%N/A7.2 $1.60
8/15/20221,600,000 shares $3.34 million -4.2%N/A6.6 $2.09
7/31/20221,670,000 shares $2.32 million -11.6%N/A15.1 $1.39
7/15/20221,890,000 shares $2.72 million +1.1%N/A16.3 $1.44
6/30/20221,870,000 shares $2.60 million +2.2%N/A13.9 $1.39
6/15/20221,830,000 shares $2.49 million -9.9%N/A12 $1.36
5/31/20222,030,000 shares $2.98 million +5.2%N/A10.1 $1.47
5/15/20221,930,000 shares $2.93 million -1.0%N/A7 $1.52
4/30/20221,950,000 shares $3.12 million -3.0%N/A5.6 $1.60
4/15/20222,010,000 shares $4.00 million +8.1%N/A3.5 $1.99
3/31/20221,860,000 shares $4.20 million -3.1%N/A1.4 $2.26
3/15/20221,920,000 shares $3.88 million -20.0%N/A0.3 $2.02
2/28/20222,400,000 shares $5.47 million -19.2%N/A0.4 $2.28
2/15/20222,970,000 shares $7.01 million -13.2%N/A0.5 $2.36
1/31/20223,420,000 shares $6.81 million -23.8%N/A0.6 $1.99
1/15/20224,490,000 shares $10.15 million +113.8%N/A0.7 $2.26
12/31/20212,100,000 shares $2.75 million -3.7%N/A0.4 $1.31
12/15/20212,180,000 shares $2.83 million -1.4%N/A5.1 $1.30
11/30/20212,210,000 shares $3.20 million -2.6%N/A5.4 $1.45
11/15/20212,270,000 shares $4.65 million -0.9%N/A5.7 $2.05
10/29/20212,290,000 shares $5.34 million +2.7%N/A6.1 $2.33
10/15/20212,230,000 shares $5.37 million -2.6%N/A5.7 $2.41
9/30/20212,290,000 shares $6.14 million -2.6%N/A6 $2.68
9/15/20212,350,000 shares $6.51 million +2.6%N/A4.8 $2.77
8/31/20212,290,000 shares $7.21 million -2.6%N/A4.3 $3.15
8/13/20212,350,000 shares $6.49 million -10.0%N/A4.1 $2.76
7/30/20212,610,000 shares $7.73 million -6.5%N/A4.5 $2.96
7/15/20212,790,000 shares $8.15 million No Change6.6%4.5 $2.92
6/30/20212,790,000 shares $9.35 million -24.8%6.6%4 $3.35
6/15/20213,710,000 shares $13.21 million -7.3%8.8%5.1 $3.56
5/28/20214,000,000 shares $14.96 million -2.7%9.4%5.2 $3.74
5/14/20214,110,000 shares $12.78 million -1.4%N/A4.4 $3.11
4/30/20214,170,000 shares $16.30 million No ChangeN/A3.7 $3.91
4/15/20214,170,000 shares $16.97 million -3.9%N/A2.9 $4.07
3/31/20214,340,000 shares $17.66 million +24.4%N/A2.9 $4.07
3/15/20213,490,000 shares $18.43 million +9.8%N/A1.9 $5.28
2/26/20213,180,000 shares $16.89 million -2.8%N/A1.8 $5.31
2/12/20213,270,000 shares $22.82 million -22.0%N/A1.9 $6.98
1/29/20214,190,000 shares $18.73 million +3.7%N/A2.7 $4.47
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

1/15/20214,040,000 shares $15.47 million +27.0%N/A3.1 $3.83
12/31/20203,180,000 shares $14.06 million +0.6%N/A2.9 $4.42
12/15/20203,160,000 shares $10.40 million -6.2%N/A3.3 $3.29
11/30/20203,370,000 shares $10.41 million +12.3%N/A5.4 $3.09
11/15/20203,000,000 shares $9.48 million -1.0%N/A4.2 $3.16
10/30/20203,030,000 shares $10.70 million +2.0%N/A3.4 $3.53
10/15/20202,970,000 shares $10.96 million -5.7%N/A3.3 $3.69
9/30/20203,150,000 shares $10.58 million -9.2%N/A2.5 $3.36
9/15/20203,470,000 shares $13.12 million -8.9%N/A2.3 $3.78
8/31/20203,810,000 shares $15.09 million +7.3%N/A2.3 $3.96
8/14/20203,550,000 shares $15.23 million -9.9%N/A2 $4.29
7/31/20203,940,000 shares $13.28 million +1.8%N/A2.3 $3.37
7/15/20203,870,000 shares $11.46 million -4.2%N/A1.4 $2.96
6/30/20204,040,000 shares $12.69 million +24.3%N/A1.5 $3.14
6/15/20203,250,000 shares $9.82 million +6.9%N/A1.3 $3.02
5/29/20203,040,000 shares $8.42 million -24.6%N/A1.1 $2.77
5/15/20204,030,000 shares $13.10 million +10.4%N/A1.3 $3.25
4/30/20203,650,000 shares $8.10 million +102.8%N/A0.6 $2.22
4/15/20201,800,000 shares $3.85 million +37.4%N/A0.3 $2.14
3/31/20201,310,000 shares $2.97 million +20.9%N/A0.2 $2.27
3/13/20201,083,900 shares $2.35 million -43.3%N/A0.4 $2.17
2/28/20201,910,000 shares $4.34 million +5.0%N/A0.3 $2.27
2/14/20201,820,000 shares $5.06 million +7.1%N/A0.3 $2.78
1/31/20201,700,000 shares $8.13 million +143.7%N/A0.5 $4.78
1/15/2020697,600 shares $1.12 million +79.1%5.3%0.3 $1.61
12/31/2019389,600 shares $498,688.00 +7.8%3.5%0.6 $1.28

GNPX Short Interest - Frequently Asked Questions

What is Genprex's current short interest?

Short interest is the volume of Genprex shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 85,200 shares of GNPX short. 3.51% of Genprex's shares are currently sold short. Learn More on Genprex's current short interest.

What is a good short interest percentage for Genprex?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.51% of Genprex's floating shares are currently sold short.

Is Genprex's short interest increasing or decreasing?

Genprex saw a increase in short interest in October. As of October 15th, there was short interest totaling 85,200 shares, an increase of 5.2% from the previous total of 81,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Genprex's float size?

Genprex currently has issued a total of 2,590,000 shares. Some of Genprex's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Genprex currently has a public float of 2,430,000 shares.

How does Genprex's short interest compare to its competitors?

3.51% of Genprex's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Genprex: Synlogic, Inc. (0.76%), Talphera, Inc. (0.21%), Tenax Therapeutics, Inc. (0.70%), Chemomab Therapeutics Ltd. (0.74%), Aspira Women's Health Inc. (4.03%), IN8bio, Inc. (0.46%), PharmaCyte Biotech, Inc. (0.30%), Avalo Therapeutics, Inc. (0.52%), Trinity Biotech plc (1.12%), Cara Therapeutics, Inc. (1.33%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Genprex stock?

Short selling GNPX is an investing strategy that aims to generate trading profit from Genprex as its price is falling. GNPX shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Genprex?

A short squeeze for Genprex occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNPX, which in turn drives the price of the stock up even further.

How often is Genprex's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNPX, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:GNPX) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners